Shenyang Xingqi Pharmaceutical Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002DV1
CNY
73.46
2.04 (2.86%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,917.96
1,451.16
1,234.22
1,014.11
678.87
532.90
420.82
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,917.96
1,451.16
1,234.22
1,014.11
678.87
532.90
420.82
Raw Material Cost
457.60
364.80
288.38
256.13
201.94
160.12
131.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.52
1.89
1.75
6.84
6.44
4.65
3.19
Selling and Distribution Expenses
855.90
670.91
584.18
434.58
312.34
285.31
238.10
Other Expenses
20.22
15.53
13.34
7.27
4.99
4.36
3.47
Total Expenditure (Excl Depreciation)
1,522.17
1,192.89
1,007.70
770.25
570.64
493.69
407.81
Operating Profit (PBDIT) excl Other Income
395.79999999999995
258.29999999999995
226.5
243.9
108.2
39.2
13
Other Income
-5.60
8.51
11.63
10.21
3.56
3.07
4.44
Operating Profit (PBDIT)
507.09
357.94
315.43
323.82
157.81
84.12
53.19
Interest
6.52
1.89
1.75
6.84
6.44
4.65
3.19
Exceptional Items
0.03
0.00
0.07
0.06
0.03
0.00
-0.96
Gross Profit (PBDT)
1,460.36
1,086.36
945.84
757.98
476.93
372.78
289.03
Depreciation
105.57
91.06
80.03
73.50
48.86
43.66
37.87
Profit Before Tax
395.03
264.99
233.72
243.54
102.54
35.82
11.17
Tax
56.97
24.96
22.03
34.43
9.08
6.31
2.16
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
338.06
240.04
211.68
194.70
87.98
35.89
13.66
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
338.06
240.04
211.68
194.70
87.98
35.89
13.66
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
14.41
5.48
-6.38
-4.65
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
338.06
240.04
211.68
209.11
93.46
29.51
9.01
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,593.17
1,689.92
1,552.31
1,344.49
682.19
568.51
545.53
Earnings per share (EPS)
1.38
0.98
0.87
0.81
0.39
0.16
0.06
Diluted Earnings per share
1.38
0.98
0.87
0.81
0.39
0.16
0.06
Operating Profit Margin (Excl OI)
21.23%
17.8%
18.13%
23.68%
15.52%
7.02%
2.59%
Gross Profit Margin
26.1%
24.54%
25.42%
31.26%
22.3%
14.91%
11.65%
PAT Margin
17.63%
16.54%
17.15%
19.2%
12.96%
6.74%
3.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 32.17% vs 17.58% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 40.88% vs 13.37% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 46.74% vs 15.01% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 242.11% vs 5.56% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Shenyang Xingqi Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,917.96
0
1,917.96
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,917.96
0
1,917.96
Raw Material Cost
457.60
0
457.60
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.52
0
6.52
Selling and Distribution Expenses
855.90
0
855.90
Other Expenses
20.22
0.00
20.22
Total Expenditure (Excl Depreciation)
1,522.17
0
1,522.17
Operating Profit (PBDIT) excl Other Income
395.79
0.00
395.79
Other Income
-5.60
0
-5.60
Operating Profit (PBDIT)
507.09
0
507.09
Interest
6.52
0
6.52
Exceptional Items
0.03
0
0.03
Gross Profit (PBDT)
1,460.36
0
1,460.36
Depreciation
105.57
0
105.57
Profit Before Tax
395.03
0
395.03
Tax
56.97
0
56.97
Provisions and contingencies
0
0
0.00
Profit After Tax
338.06
0
338.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
338.06
0
338.06
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
338.06
0
338.06
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,593.17
0
1,593.17
Earnings per share (EPS)
1.38
0
1.38
Diluted Earnings per share
1.38
0
1.38
Operating Profit Margin (Excl OI)
21.23%
0%
0.00
21.23%
Gross Profit Margin
26.10%
0%
0.00
26.10%
PAT Margin
17.63%
0%
0.00
17.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 191.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 32.17% vs 17.58% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 33.81 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 40.88% vs 13.37% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 51.27 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 46.74% vs 15.01% in Dec 2023

Annual - Interest
Interest 0.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 242.11% vs 5.56% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.23%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023